Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial is evaluating UTAA91 Injection for relapsed/refractory autoimmune diseases. The study is not yet recruiting …
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of low-dose interleukin-2 in patients with systemic lupus erythematosus and cytome…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Retrospective chart review describing the experience of systemic lupus erythematosus patients treated with anifrolumab in early access progr…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus [EARLY_Phase 1]
An early-phase 1 clinical trial from Zhejiang University evaluating UCAR T-cell therapy targeting CD19/BCMA in patients with relapsed/refrac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus [EARLY_Phase 1]
This is an early-phase 1 exploratory clinical study evaluating anti-CD19 CAR NK cells for systemic lupus erythematosus and it is currently r…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE [Phase 1]
Phase 1 clinical trial evaluating BCMA/CD70 CAR-T therapy for refractory childhood-onset systemic lupus erythematosus (cSLE) is currently re…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus [Phase 1]
An open-label Phase 1 trial of GB261 for refractory seropositive systemic lupus erythematosus is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Chinese Rheumatism Biobank(CRB)
This clinical trial update notes that the NCT06887517 study by the Chinese SLE Treatment And Research Group is currently recruiting for syst…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Physical Activity in Patients With Systemic Lupus Erythematosus
A clinical trial evaluating physical activity in patients with systemic lupus erythematosus is listed, and it is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus [Phase 1]
Phase 1 clinical trial update evaluating the safety of intravenously infused allogeneic umbilical cord-derived mesenchymal stem cells for sy…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases [NA]
An active, not-recruiting clinical trial at Northwestern University is studying vaccine hesitancy among Black/African American patients with…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children [Phase 3]
This document updates on a Phase 3 clinical trial evaluating CAR-T cell therapy for refractory or recurrent lupus nephritis in children, whi…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
A clinical trial in Martinique is evaluating chlordecone impregnation for systemic lupus erythematosus with renal involvement; recruitment i…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) [NA]
Clinical trial update indicates ongoing recruitment for Equecabtagene autoleucel (Eque-cel), a CAR-T therapy, for relapsed/refractory system…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Adjunctive Yu-Tone Music Therapy for Systemic Lupus Erythematosus: a Prospective Cohort Study
This update describes an ongoing prospective cohort study evaluating Yu-Tone music therapy as an adjunct to standard care for systemic lupus…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial evaluating CD19/BCMA CAR-T cell therapy for refractory or moderate-to-severe systemic lupus erythematosus. The study …
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
An early-phase trial evaluating the safety and efficacy of IC19 CAR-T Cell Therapy for refractory systemic lupus erythematosus is not yet re…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
A Strasbourg-based study is evaluating whether physician consideration of electronic patient-reported outcomes from patients with gout, rheu…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Blood Indices in Systemic Lupus Erythematosus
This clinical trial update reports on assessing blood indices in patients with systemic lupus erythematosus; the study is currently not yet …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
A completed study developing a decision aid to help lupus patients understand hydroxychloroquine and dispel common misbeliefs about its use.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
Clinical trial update for a Phase 2 study of TQB3702 tablets in systemic lupus erythematosus; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial update for ZM001 injection in refractory systemic lupus erythematosus; currently not yet recruiting.